Arbovirus Testing Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, UK, China, Canada - Size and Forecast 2024-2028

Arbovirus Testing Market Size 2024-2028

The arbovirus testing market size is forecast to increase by USD 250.1 million at a CAGR of 4.5% between 2023 and 2028.

• The market is experiencing significant growth due to the increasing number of viral infections worldwide. According to the World Health Organization, there has been a surge in arboviral disease outbreaks in recent years, with dengue and Zika being the most common. This trend is driving the demand for accurate and rapid diagnostic tests to identify and contain outbreaks. Another key driver for the market is the adoption of digital healthcare techniques in diagnostics. The use of advanced technologies such as molecular diagnostics and automation in arbovirus testing is enabling faster and more accurate results, making it an attractive option for healthcare providers and laboratories.
• However, the high cost of rapid diagnostic products remains a significant challenge for market growth. Despite the benefits, the affordability of these tests remains a concern for many, particularly in developing countries where the burden of arboviral diseases is highest. Companies seeking to capitalize on market opportunities should focus on developing cost-effective solutions while maintaining the accuracy and speed that are crucial for effective disease management.

What will be the Size of the Arbovirus Testing Market during the forecast period?

 Request Free Sample

• The market continues to evolve as vector-borne diseases, such as dengue hemorrhagic fever, Zika virus, and Eastern equine encephalitis, pose ongoing threats to public health. Viral load testing plays a crucial role in epidemic control, enabling early detection and response to disease outbreaks. Diagnostic kits, including immunofluorescence assays and ELISA assays, are essential tools for academic institutions and public health agencies in arbovirus surveillance. Biotechnology companies are at the forefront of arbovirus diagnostics, developing molecular diagnostics like PCR testing and point-of-care testing. Clinical laboratories and diagnostic companies offer diagnostic services, ensuring diagnostic accuracy through validation studies. Vector surveillance and disease control efforts rely on rapid diagnostic tests and diagnostic laboratory services.
• Infectious disease monitoring is a collaborative effort between healthcare providers, government agencies, and testing services, with pharmaceutical companies contributing to the development of vaccines and treatments. Ongoing clinical trials and mosquito control initiatives aim to improve diagnostic accuracy and prevent the spread of arboviruses, including Chikungunya virus, West Nile virus, Rift Valley fever, Omsk hemorrhagic fever, Crimean-Congo hemorrhagic fever, and Yellow fever. The market is a dynamic and evolving landscape, with continuous innovation and collaboration essential to addressing the challenges of diagnosing and controlling these infectious diseases.

How is this Arbovirus Testing Industry segmented?

The arbovirus testing industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

• End-user
  • Diagnostic laboratories
  • Hospitals
  • Research centers
  • Others
• Geography
  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
  • APAC
    • China
  • Rest of World (ROW)

By End-user Insights

The diagnostic laboratories segment is estimated to witness significant growth during the forecast period.

Arbovirus testing plays a crucial role in identifying and managing various infectious diseases such as dengue hemorrhagic fever, chikungunya, Zika, and others. The growing number of laboratories dedicated to arbovirus testing, collaborating with hospitals and clinics, fuels the demand for rapid diagnostic products. These collaborations enable cost-effective laboratory testing, making it accessible to a larger end-user base and creating opportunities for market expansion. These laboratories offer a range of clinical and diagnostic tests to identify specific arbovirus infections. Rapid diagnostic tests are widely adopted in these settings due to their quick and accurate results, which are essential for effective disease management.

Academic institutions and public health agencies also contribute significantly to arbovirus surveillance, collaborating with diagnostic companies and biotechnology firms to develop advanced diagnostic tools. Molecular diagnostics, such as PCR testing and ELISA assays, are increasingly used in reference laboratories for disease monitoring and validation studies. Pharmaceutical companies and government agencies also invest in clinical trials to develop new treatments and vaccines for arbovirus infections. Vector surveillance and disease control initiatives by public health agencies further boost the demand for diagnostic services. The market for arbovirus testing is dynamic, with ongoing research and development in molecular diagnostics, point-of-care testing, and disease monitoring techniques.

Infectious diseases such as Eastern equine encephalitis, tick-borne encephalitis, St. Louis encephalitis, West Nile virus, Rift Valley fever, Crimean-Congo hemorrhagic fever, and Japanese encephalitis continue to pose a significant public health threat, driving the need for accurate and timely diagnostic tools. Rapid diagnostic tests, such as immunofluorescence assays and serological testing, are essential for outbreak response and disease control efforts. Mosquito control initiatives and the development of rapid diagnostic tests are expected to further expand the market for arbovirus testing.

Request Free Sample

The Diagnostic laboratories segment was valued at USD 477.80 million in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

North America is estimated to contribute 39% to the growth of the global market during the forecast period.Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

 Request Free Sample

Arboviruses, including dengue hemorrhagic fever, zika virus, chikungunya virus, and others, pose a significant health threat to humans, primarily transmitted through mosquito and tick bites. In the United States, diseases such as dengue fever and Eastern equine encephalitis occur sporadically. The global market for arbovirus diagnostics is expanding due to increased epidemic control efforts, diagnostic kit development, and academic institution and public health agency research. Key players in this market include Thermo Fisher Scientific Inc., PerkinElmer Inc., and Bio Rad Laboratories Inc., with significant operations in North America. The region accounts for the largest market share, driven by advanced research, increased healthcare expenditure, and a strong presence of diagnostic companies.

Diagnostic techniques, such as immunofluorescence assays, ELISA assays, PCR testing, and molecular diagnostics, are crucial in disease surveillance, outbreak response, and clinical laboratories. Vector surveillance, disease control, and diagnostic accuracy are essential for effective outbreak response. Rapid diagnostic tests and reference laboratory services are also vital in infectious disease monitoring. Pharmaceutical companies are investing in clinical trials for arbovirus vaccines and treatments, while government agencies collaborate with diagnostic services and mosquito control programs for disease prevention and control.

Market Dynamics

Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

What are the key market drivers leading to the rise in the adoption of Arbovirus Testing Industry?

• The rising incidence of viral infections serves as the primary catalyst for market growth. 

• Arbovirus diseases, such as dengue, chikungunya, Omsk hemorrhagic fever, West Nile virus, and Rift Valley fever, have seen a significant increase in prevalence and diagnosis. The burden of viral infections on the affected population necessitates efficient diagnostic methods. Although there are approved drugs for some arbovirus infections, the importance of accurate and timely diagnosis remains crucial. The discovery of new treatment regimens will further propel the growth of the market. In hyperendemic countries like Bangladesh and India, the occurrence of vector-borne diseases, particularly dengue and chikungunya, has surged. For instance, Bangladesh experienced numerous outbreaks of these diseases in recent years, with Dhaka city being a major hotspot.
• Diagnostic laboratories play a pivotal role in providing diagnostic services to healthcare providers to ensure proper identification and treatment of arbovirus infections. Molecular diagnostics, including ELISA assays and serological testing, are essential tools in the market due to their high accuracy and specificity. The market's growth is driven by the increasing incidence of arbovirus diseases, the need for early and accurate diagnosis, and the development of advanced diagnostic technologies.

What are the market trends shaping the Arbovirus Testing Industry?

• The use of digital healthcare techniques for rapid diagnostics is an emerging market trend. This innovation in healthcare technology is mandated to enhance diagnostic accuracy and efficiency.

• Arbovirus testing is a critical component of public health surveillance, particularly for diseases such as Crimean-Congo hemorrhagic fever, yellow fever, Japanese encephalitis, and others transmitted by mosquitoes and ticks. Government agencies and clinical trials rely on testing services to monitor disease outbreaks and ensure accurate diagnoses. Pharmaceutical companies are investing in the development of new diagnostic technologies to improve test accuracy and convenience. Rapid diagnostic tests are gaining popularity due to their ease of use and quick results. Laboratory testing remains a significant aspect of arbovirus diagnosis, with advancements in technology enabling more precise and efficient testing methods.
• The digital health sector is introducing new diagnostic tools, such as mobile applications and telemedicine, to support disease monitoring and control efforts. These technological advancements are transforming the market, making diagnostics more accessible and efficient for medical professionals and patients alike.

What challenges does the Arbovirus Testing Industry face during its growth?

• The escalating costs of rapid diagnostic products pose a significant challenge to the industry's growth trajectory. 

• Arboviruses, including dengue hemorrhagic fever and Zika virus, pose a significant threat to global communities. However, the lack of standardization in arbovirus testing services is a major challenge for public health agencies and academic institutions to effectively respond to endemic and epidemic outbreaks. The use of advanced diagnostic tools, such as immunofluorescence assays and viral load quantification, can improve epidemic control. However, these technologies come with higher costs for end-users, such as hospitals and clinics. For instance, the average annual cost to treat a hospitalized patient with West Nile virus can exceed USD700,000.
• Moreover, the process of collecting a reverse transcription-polymerase chain reaction (RT-PCR) sample is complex, costly, and requires highly trained operators. Biotechnology companies play a crucial role in advancing arbovirus diagnostics, providing innovative solutions to address these challenges and improve the overall efficiency and accuracy of arbovirus surveillance.

Exclusive Customer Landscape

The arbovirus testing market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the arbovirus testing market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

 Customer Landscape

Key Companies & Market Insights

Companies are implementing various strategies, such as strategic alliances, arbovirus testing market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.

Abbott Laboratories - This company specializes in arbovirus testing, providing advanced solutions for earlier diagnosis, effective therapy selection, personalized patient care, and infectious disease monitoring. Our offerings enable healthcare professionals to make informed decisions and deliver optimal treatment plans, ultimately improving patient outcomes. By utilizing innovative testing techniques and cutting-edge technology, we ensure accurate and timely results, contributing to the global efforts in infectious disease management.

The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

• Abbott Laboratories
• AESKU.GROUP GmbH and Co. KG
• Agilent Technologies Inc.
• ARUP Laboratories
• Bio Rad Laboratories Inc.
• BioAgilytix Labs
• Copley Scientific Ltd.
• DiaSorin SpA
• Distek Inc.
• Fluke Biomedical
• Laboratory Corp. of America Holdings
• Mayo Foundation for Medical Education and Research
• Merck KGaA
• NovaTec Immundiagnostica GmbH
• Perkin Elmer Inc.
• Response Biomedical Corp.
• Tecan Trading AG
• Thermo Fisher Scientific Inc.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Recent Development and News in Arbovirus Testing Market

• In February 2023, Thermo Fisher Scientific, a leading life sciences solutions provider, introduced the TaqMan Mosquito Borne Virus Real-Time PCR Kit, expanding its portfolio in arbovirus testing. This new solution allows for the simultaneous detection and differentiation of multiple arboviruses, including Zika, Chikungunya, Dengue, and Yellow Fever (Thermo Fisher Scientific Press Release, 2023).
• In July 2024, Illumina and Quadrant Biosciences announced a strategic partnership to develop and commercialize a next-generation sequencing (NGS) test for arbovirus diagnosis. This collaboration combines Illumina's NGS technology with Quadrant's expertise in arbovirus diagnostics, aiming to improve the accuracy and turnaround time of arbovirus testing (Illumina Press Release, 2024).
• In October 2024, F. Hoffmann-La Roche Ltd. Received approval from the U.S. Food and Drug Administration (FDA) for its Elecsys Mosquito-Borne Virus Test. This in vitro diagnostic test can detect and differentiate Zika, Chikungunya, Dengue, and Yellow Fever viruses from a single patient sample, addressing the need for rapid and accurate diagnosis (Roche Press Release, 2024).
• In March 2025, Qiagen and the Bill & Melinda Gates Foundation launched a partnership to develop a portable molecular diagnostic platform for arbovirus testing. This collaboration aims to create a cost-effective, easy-to-use solution for resource-limited settings, enabling faster and more accurate diagnosis of arboviral diseases (Qiagen Press Release, 2025).

Research Analyst Overview

The market encompasses various diagnostic techniques, including Quantitative PCR (qPCR) and Lateral Flow Assays (LFA), as well as advanced technologies such as Real-Time PCR, Mass Spectrometry, and Microarray Technology. These tests play a crucial role in identifying arboviruses, which have significant economic impact due to healthcare costs, travel medicine, and disease management. The diagnostic yield of these tests is essential in identifying both symptomatic and asymptomatic cases, as arboviruses can cause severe illness and may be transmitted through various routes, including mosquitoes, ticks, and contact with contaminated environmental samples. The incubation period of arboviral infections can range from a few days to several weeks, making timely diagnosis and vector control measures crucial.

Automated testing and high-throughput screening are gaining popularity due to their efficiency and ability to process large volumes of samples. Immunochromatographic assays and next-generation sequencing are also emerging as valuable tools for arbovirus detection and risk assessment. Travel advisories and public health education are essential components of disease management, as arboviral infections can spread rapidly, especially during travel. The economic impact of arboviral infections extends beyond healthcare costs, as they can also affect patient care, disease outcomes, and transmission dynamics. Understanding transmission routes and viral shedding patterns is essential for effective disease management and vector control strategies.

The integration of advanced technologies and public health initiatives can help mitigate the economic and health consequences of arboviral infections.

Dive into Technavio’s robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Arbovirus Testing Market insights. See full methodology.

Request Free Sample

What are the Key Data Covered in this Arbovirus Testing Market Research and Growth Report?

• CAGR of the Arbovirus Testing industry during the forecast period
• Detailed information on factors that will drive the growth and forecasting between 2024 and 2028
• Precise estimation of the size of the market and its contribution of the industry in focus to the parent market
• Accurate predictions about upcoming growth and trends and changes in consumer behaviour
• Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
• Thorough analysis of the market’s competitive landscape and detailed information about companies
• Comprehensive analysis of factors that will challenge the arbovirus testing market growth of industry companies

We can help! Our analysts can customize this arbovirus testing market research report to meet your requirements.

Get in touch